{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T08:04:15Z","timestamp":1720080255250},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ejpb.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T20:18:04Z","timestamp":1457468284000},"page":"115-122","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating and optimizing oral formulations of live bacterial vaccines using a gastro-small intestine model"],"prefix":"10.1016","volume":"102","author":[{"given":"Jo\u00e3o M.S.","family":"de Barros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Costabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Charalampopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaliy V.","family":"Khutoryanskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander D.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ejpb.2016.03.010_b0005","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2006.03.039","article-title":"Enteric infections and the vaccines to counter them: future directions","volume":"24","author":"Levine","year":"2006","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.ejpb.2016.03.010_b0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0264-410X(00)00354-6","article-title":"Use of live bacterial vaccine vectors for antigen delivery: potential and limitations","volume":"19","author":"Medina","year":"2001","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.ejpb.2016.03.010_b0015","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1128\/AEM.01019-08","article-title":"Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes","volume":"74","author":"Duan","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"issue":"3","key":"10.1016\/j.ejpb.2016.03.010_b0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1541-4337.2010.00110.x","article-title":"Functional foods and nondairy probiotic food development: trends, concepts, and products","volume":"9","author":"Granato","year":"2010","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"issue":"2","key":"10.1016\/j.ejpb.2016.03.010_b0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mimet.2006.02.017","article-title":"Preservation of micro-organisms by drying; a review","volume":"66","author":"Morgan","year":"2006","journal-title":"J. Microbiol. Methods"},{"issue":"38","key":"10.1016\/j.ejpb.2016.03.010_b0030","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1016\/j.vaccine.2015.07.073","article-title":"Peru-15 (Choleragarde\u00ae), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand","volume":"33","author":"Ratanasuwan","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejpb.2016.03.010_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"Chen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2016.03.010_b0040","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"8720","key":"10.1016\/j.ejpb.2016.03.010_b0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2016.03.010_b0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12866-015-0409-5","article-title":"Use of Ensure(R) nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines","volume":"15","author":"Brenneman","year":"2015","journal-title":"BMC Microbiol."},{"issue":"7351","key":"10.1016\/j.ejpb.2016.03.010_b0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","article-title":"Detection of prokaryotic mRNA signifies microbial viability and promotes immunity","volume":"474","author":"Sander","year":"2011","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.ejpb.2016.03.010_b0060","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.vaccine.2009.04.006","article-title":"Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins","volume":"27","author":"Edwards","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejpb.2016.03.010_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nbt.2013.09.001","article-title":"Protection of dried probiotic bacteria from bile using bile adsorbent resins","volume":"31","author":"Mahbubani","year":"2014","journal-title":"New Biotechnol."},{"issue":"45","key":"10.1016\/j.ejpb.2016.03.010_b0070","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2008.08.024","article-title":"Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance","volume":"26","author":"Edwards","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ejpb.2016.03.010_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.09.012","article-title":"Polymer blends for controlled release coatings","volume":"125","author":"Siepmann","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2016.03.010_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2012.06.003","article-title":"Microencapsulation of probiotics for gastrointestinal delivery","volume":"162","author":"Cook","year":"2012","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ejpb.2016.03.010_b0085","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jps.23997","article-title":"A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria","volume":"103","author":"de Barros","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2016.03.010_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijfoodmicro.2004.08.020","article-title":"A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics","volume":"99","author":"Mainville","year":"2005","journal-title":"Int. J. Food Microbiol."},{"issue":"2","key":"10.1016\/j.ejpb.2016.03.010_b0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.copbio.2007.01.011","article-title":"Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut","volume":"18","author":"Macfarlane","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.ejpb.2016.03.010_b0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002489900072","article-title":"Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon","volume":"35","author":"Macfarlane","year":"1998","journal-title":"Microb. Ecol."},{"key":"10.1016\/j.ejpb.2016.03.010_b0105","doi-asserted-by":"crossref","unstructured":"MINEKUS, et al., A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. Vol. 23, 1995, Nottingham, ROYAUME-UNI: Fund for the Replacement of Animals in Medical Experiments.","DOI":"10.1177\/026119299502300205"},{"issue":"2","key":"10.1016\/j.ejpb.2016.03.010_b0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00228615","article-title":"Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem","volume":"39","author":"Molly","year":"1993","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"8","key":"10.1016\/j.ejpb.2016.03.010_b0115","doi-asserted-by":"crossref","first-page":"e23227","DOI":"10.1371\/journal.pone.0023227","article-title":"The influence of Staphylococcus aureus on gut microbial ecology in an in vitro continuous culture human colonic model system","volume":"6","author":"Sannasiddappa","year":"2011","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.ejpb.2016.03.010_b0120","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1016\/j.ces.2010.05.030","article-title":"Optimal protection of stabilised dry live bacteria from bile toxicity in oral dosage forms by bile acid adsorbent resins","volume":"65","author":"Edwards","year":"2010","journal-title":"Chem. Eng. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2016.03.010_b0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1023\/A:1015937912504","article-title":"Kinetics of release from enteric-coated tablets","volume":"5","author":"Ozturk","year":"1988","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116300868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116300868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T21:37:01Z","timestamp":1600292221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116300868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"alternative-id":["S0939641116300868"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.03.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating and optimizing oral formulations of live bacterial vaccines using a gastro-small intestine model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}